1 / 29

Inflammatory Bowel Disease - PowerPoint PPT Presentation

  • Updated On :

INFLAMMATORY BOWEL DISEASE. Norman H. Gilinsky, M.D., FACP, FACG Associate Professor of Medicine Medical Director, Digestive Diseases Center University of Cincinnati. Objectives At completion of this lecture, the student will be able to:.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Inflammatory Bowel Disease' - Jimmy

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Slide1 l.jpg


Norman H. Gilinsky, M.D., FACP, FACG

Associate Professor of Medicine

Medical Director, Digestive Diseases Center

University of Cincinnati

Slide2 l.jpg

ObjectivesAt completion of this lecture, the student will be able to:

  • Describe the main manifestations of each of the inflammatory bowel disorders

  • State the main clinical features that differentiate Crohn’s disease from ulcerative colitis

  • Formulate a management plan for diagnosis of disease extent and severity of each disorder

  • Develop a strategy to treat each disease

  • Differentiate treatment modalities that are more applicable to the management of Crohn’s disease than ulcerative colitis

Inflammatory bowel disease ulcerative colitis and crohn s disease l.jpg
Inflammatory Bowel DiseaseUlcerative Colitis and Crohn’s Disease


  • Chronic inflammation, usually limited to GIT

  • Majority young, therefore life-long disorder

  • Natural history: tends to relapse

  • Medications utilized generally similar


  • Anatomic location and pathology (and therefore, presentation)

  • Nutritional consequences

  • Response to medical therapies

  • Surgical strategy, if required

Slide4 l.jpg

IBD: Location and Extent

5% Gastroduodenitis

40% Distal/ Left-sided colitis

30% Proctitis

25% Colitis

40% Ileocolitis

30% Ileitis

30% Extensive/ Pancolitis

Ulcerative Colitis Crohn’s Disease

Ibd pathogenesis l.jpg

Chromosome 16 (IBD1)

Chromosome 12 (IBD2)

Chromosome 6 (IBD3-HLA)

Chromosome 14


Genetic susceptibility






Immune dysregulation

Environmental trigger

TH 1

TH 2

Ahmad et al, Aliment Pharmacol Ther 2001; Hugot et al, Science 2001

Inflammatory bowel disease extra intestinal manifestations l.jpg
Inflammatory Bowel DiseaseExtra-Intestinal Manifestations


  • Peripheral arthritis

  • Ankylosing spondylitis, sacroileitis


  • Pyoderma gangrenosum, Erythema nodosum


  • Episcleritis, uveitis, keratoconjunctivitis


  • Sclerosing cholangitis,cholangiocarcinoma


  • Hypercoagulability

Ulcerative colitis clinical features l.jpg
Ulcerative Colitis – Clinical Features

Presents with bloody diarrhea

  • Majority have limited left-sided disease

  • Majority consitutionally well

  • Majority safely managed in office setting

  • Profuse bloody diarrhea; >6 stools/day

  • Weight loss, anemia, hypoalbuminemia

  • Fever, abdominal pain, distension

Red Flags

Ulcerative colitis differential diagnosis l.jpg
Ulcerative Colitis: Differential Diagnosis


  • Salmonella, shigella, campylobacter, amebiasis, etc.






Practice Point: Consider clinical setting, stool studies

Ulcerative colitis consequences of disease l.jpg
Ulcerative Colitis: Consequences of Disease


  • Fluid, electrolyte disturbance

  • Anemia

  • Fulminant colitis, toxic megacolon, perforation


  • Related to chronic disease, treatment

  • Related to extra-intestinal manifestations

  • Cancer

Colorectal cancer in ibd l.jpg
Colorectal Cancer in IBD

  • Increased risk associated with:

    • Duration of disease

    • Anatomic extent of disease

  • Cancers develop in a dysplasia-to-cancer sequence

  • Cancers often flat, multiple, at advanced stage.

Practice Point: Colonoscopy with biopsy necessary for periodic cancer surveillance in patients with IBD.

Ulcerative colitis diagnostic work up l.jpg
Ulcerative Colitis - Diagnostic Work-Up

  • Clinical suspicion

  • Stool studies

  • Endoscopy (with biopsy)

  • (Radiology)

  • Hematology and biochemistry (especially if clinically severe – i.e. CBC, albumin, electrolytes)

  • Serologies (if uncertainties remain, e.g. amebiasis; specific IBD serologies experimental)

Slide12 l.jpg

IBD: Treatment Modalities

5-Aminosalicylic Acid

[sulfasalazine, mesalamine]

Administered topically PO and/or PR


Administered PO, PR or IV


[6-MP, Azothioprine, Cyclosporine, etc]


Inflammatory bowel disease sulfasalazine 5 aminosalicylates l.jpg
Inflammatory Bowel DiseaseSulfasalazine / 5-Aminosalicylates

  • Ulcerative colitis

    • Induction therapy in mild to moderate disease (anticipate about 80% response)

    • Maintenance therapy, to reduce chances of relapse, once remission obtained

  • Crohn’s disease

    • Data not convincing

    • Best effects with high doses and for ileal disease

  • Balsalazide

Slide14 l.jpg

Inflammatory Bowel DiseaseSulfasalazine / 5-Aminosalicylates

5-ASA-diazo bond-sulfapyradine

  • Action

    • Topical / mucosal anti-inflammatory

  • Side-effects

    • Intolerance [gastric distress, headache]

    • Allergy

    • Cytopenias, hemolysis, folate deficiency

    • Nephritis, hepatitis

    • Pneumonitis, pancreatitis

    • Hypospermia

  • Balsalazide

Slide15 l.jpg

Inflammatory Bowel DiseaseMesalamine (5-ASA preparations)

  • Route of administration

    • Oral

    • Enema

    • Suppository

  • Side-effect profile

    • Less intolerance

    • No hypospermia, folate deficiency

  • Efficacy

    • No better (than sulfasalazine) for colitis

  • Cost

    • More expensive

  • Balsalazide

Inflammatory bowel disease role of corticosteroids l.jpg
Inflammatory Bowel DiseaseRole of Corticosteroids

  • Good drug for controlling acute flare (available oral, rectal or IV – use depending on disease location, clinical severity)

  • Of no value in maintenance situation

  • High frequency side-effects

  • Symptoms may flare with tapering

  • Steroid dependency common

Slide17 l.jpg

Inflammatory Bowel DiseaseRole of Immunosuppressive Agents

6-Mercaptopurine, azathioprine, methotrexate, cyclosporine

  • Steroid-sparing

  • Induces remission in majority

  • Speed of onset variable

  • Maintains remission

  • Useful in chronic grumbling disease, wish to avoid surgery, compliant patient

  • Requires periodic monitoring

  • Generally acceptable side-effect profile

Slide18 l.jpg

Inflammatory Bowel DiseaseManagement of Severe Colitis

  • Hospitalize, IV therapy

  • IV steroids, antibiotic cover

  • May require nutritional support

  • Rule out infection, megacolon

  • Frequent monitoring

    • Clinical condition, vitals

    • CBC, albumin

    • Radiology

  • Surgery if deteriorates, doesn’t settle

  • Concern = perforation, high relapse rate

Slide19 l.jpg

Crohn’s Disease:

Main Characteristics (1)

  • Any or > 1 region of GIT involved (perianal, skip areas)

  • Colon spared in > 20%

  • Small bowel involved in > 60%; therefore predisposed to nutritional sequelae, malabsorption, metabolic disorders, trace element and vitamin deficiencies

  • Inflammation transmural, therefore efficiency of topical therapy limited

Slide20 l.jpg

Crohn’s Disease:

Main Characteristics (2)

  • Disease pathology diverse

    • Inflammatory

    • Stricturing

    • Perforating

  • Presentation and outcome therefore diverse

  • No ‘cure’, therefore surgery (if required) limited to localized complications

  • Recurrences post-surgery not unusual

Crohn s disease presentation l.jpg
Crohn’s Disease - Presentation


  • Pain, tenderness, diarrhea, RLQ mass


  • Cramps, distension, vomiting, obstruction


  • Enererocutaneous, enteroenteric, rectovaginal, enterovesical, etc.

Crohn s disease disease consequences l.jpg
Crohn’s Disease: Disease Consequences


  • Fevers, weight loss, debilitation, pain

    Nutritional sequelae

  • Malabsorption, depletion syndromes

  • Growth retardation

    Perianal involvement

  • Abscess, fissure, fistula


  • Short-bowel syndrome

  • Renal calculi, gallstones

  • QOL, Psychologic

Slide23 l.jpg

Crohn’s Disease: Differential Diagnosis

  • Infectious etiologies

  • CMV, TB, Yersinia, C difficile, toxigenic E coli, etc.

  • Appendicitis

  • Diverticulitis

  • Ischemia

  • Carcinoma, lymphoma

  • Ulcerative colitis

  • Celiac disease

Practice Point: Great mimicker

Slide24 l.jpg

Crohn’s Disease - Diagnostic Work-Up

  • Clinical suspicion

  • Stool studies

  • Endoscopy (with biopsy)

  • Radiology

    • Abdominal X-ray

    • Small bowel follow-through

    • CT scan, etc.

  • Hematology and biochemistry (especially if clinically severe – i.e. CBC, albumin, electrolytes)

  • Malabsorption

  • Serologies (specific IBD serologies experimental)

Slide25 l.jpg

Crohn’s Disease: Treatment Modalities

5-Aminosalicylic Acid

Biologic Agents

[Monoclonal antibodies – Infliximab]




Nutritional Aspects


Psychologic Support

The future biologic therapies l.jpg
The future – Biologic Therapies?

  • Approved

    TNF- antibodies (infliximab, Remicade®)

  • Experimental

    • CDP-571

    • Interleukin 10

    • Gene therapies?

Inflammatory bowel disease other issues for the specialist and primary care physician l.jpg
Inflammatory Bowel DiseaseOther Issues for the Specialist and Primary Care Physician

  • Perineal / ano-rectal disease [CD]

  • Symptomatic fistula [CD]

  • Short bowel syndrome / nutritional support [CD]

  • The pediatric and adolescent patient

  • The pregnant patient

  • Bone disease

  • Work and Psychologic issues

Ibd indications for surgery l.jpg


Failure of medical therapy

Dysplasia or carcinoma

Debility, poor QOL

Intolerant of medications

Massive hemorrhage, perforation

Intractable pyoderma, hemolysis

Directed to specific complication

Symptomatic obstruction

Symptomatic fistulae



Dysplasia or carcinoma

Perianal disease

IBD: Indications for Surgery

Ulcerative Colitis Crohn’s Disease

Ibd other key references l.jpg
IBD: Other Key References

  • Your Internal Medicine Textbook – plus:

  • Hanauer et al. Management of Crohn’s disease in adults. Am J Gastroenterol 2001; 96:634-43

  • Kornbluth et al. Ulcerative colitis practice guidelines in adults. Am J Gastroenterol 1996; 92:204-211

  • Lichtenstein. Inflammatory bowel disease. Gastroenterol Clin N Am 1999; 28:2